Filter Options
Required*
Filter
Santa Cruz / California / Türkiye
0.0
SomaGenics develops and provides novel RNA-based gene inhibitors for functional genomics and therapeutics. The company specializes in tools and technologies for drug discovery. It researches inflammatory and autoimmune disorders, HIV and hepatitis C. SomaGenics primary platform technology is a gene-targeting approach called the RNA Lasso. RNA Lassos have potential applications in drug target discovery, therapeutics, research, and diagnostics. The RNA Lasso platform technology provides a significant advance in addressing diagnostics for research, agricultural, veterinary, food, and medical testing, as well as drug development and discovery. In addition to therapeutic development, SomaGenics has several technology applications available for licensing with partners. The company is based in Santa Cruz, Calif.
Santa Cruz / California / Türkiye
0.0
Santa Cruz Biotechnology is focused on the ongoing development of research antibodies, with a goal of offering the broadest range of research reagents in the field. The company offers more than 2,850 target-specific 19-25 nucleotide siRNAs that can be used to knockdown protein expression in a broad variety of mammalian cell types. Its primary product line includes siRNAs designed to silence a large selection of proteins including tumor suppressors, kinases, transcription regulators, cell cycle proteins, membrane receptors, kinases, signaling intermediates, cell adhesion proteins and proteins involved in lymphocyte signaling. The company s secondary product line provides a new method for the detection of immunoprecipitated proteins via western blot analysis. Santa Cruz Biotechnology offers online ordering for all its products. The company is headquartered in Santa Cruz, Calif.